ロード中...
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
BACKGROUND: The calcineurin (CaN) inhibitor, tacrolimus, is widely used in patients undergoing allogeneic organ transplantation and in those with certain allergic diseases. Recently, several reports have suggested that CaN is also associated with schizophrenia. However, little data are currently ava...
保存先:
| 出版年: | Neuropsychiatr Dis Treat |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940021/ https://ncbi.nlm.nih.gov/pubmed/27462157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S106371 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|